[October 20, 2014]

Pathway Genomics Launches Patient Mobile App at ASHG 2014

Pathway Genomics Corporation, a CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced it has released a patient app that allows existing patients to view their genetic results on mobile devices, such as smart phones and tablets. The announcement was made at the 64^th Annual Meeting of the American Society of Human Genetics (ASHG) in San Diego, California.

"Pathway's patient app empowers the individual to view their genetic testing results with a push of a button from their mobile device," said Jim Plante, Pathway Genomics' founder and CEO. "Patients can now have their genetic testing results accessible at all times."

Available on both the iOS and Android (News - Alert) mobile operating systems, and available via the App Store and Google Play, Pathway's patient app contains a number of different features and functions for retrieving and viewing actionable genetic testing results.

"Genetic testing results are powerful, but not always easy to access," said Ardy Arianpour, Pathway Genomics' chief strategy officer. "Our patient app is a simple tool to carry your genetic tests in the palm of your hand. Existing and new customers can import their genetic test results within minutes by downloading our app."

Pathway's patient app is continuously evolving and being enhanced. For more information about Pathway Genomics' app, read more about it and download it at the App Store or Google Play.

About Pathway Genomics Corporation

As a CLIA and CAP accredited clinical laboratory based in San Diego, California, Pathway Genomics provides physicians and their patients with actionable and accurate genetic information to improve or maintain health and wellness. Since its founding in 2008, Pathway Genomics has become known for its dedication to innovation and commitment to medical responsibility - making it a leader in the commercial genetic testing industry. Pathway Genomics' testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit www.pathway.com.

[ Back To TMCnet.com's Homepage ]